Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Saudi Advanced Industries Company SJSC
SAU:2120
|
SA |
Fine Foods & Pharmaceuticals NTM SpA
Total Equity
Fine Foods & Pharmaceuticals NTM SpA
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
Total Equity
€137.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Stevanato Group SpA
NYSE:STVN
|
Total Equity
€1.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fine Foods & Pharmaceuticals NTM SpA
Glance View
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 768 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
See Also
What is Fine Foods & Pharmaceuticals NTM SpA's Total Equity?
Total Equity
137.8m
EUR
Based on the financial report for Sep 30, 2025, Fine Foods & Pharmaceuticals NTM SpA's Total Equity amounts to 137.8m EUR.
What is Fine Foods & Pharmaceuticals NTM SpA's Total Equity growth rate?
Total Equity CAGR 3Y
2%
Over the last year, the Total Equity growth was 6%. The average annual Total Equity growth rates for Fine Foods & Pharmaceuticals NTM SpA have been 2% over the past three years .
